Brain, new growths of, malignant (DC 8002)
DC 8002 covers malignant (cancerous) new growths of the brain. The VA rates DC 8002 at 100% during active malignant disease, with a 30% minimum rating that protects you from a lower evaluation. Per the CFR Note, the 100% rating continues for 2 years after the last surgical, chemotherapeutic, or other treatment ends. At the 2-year mark, if the residuals have stabilized, the rating is shifted to neurological residuals according to symptomatology (rated under the appropriate diagnostic codes in 38 CFR § 4.124a, for example, seizures, paralysis, cognitive impairment, or cranial nerve damage), with the 30% minimum rating preserved as a floor.
Disclaimer: This tool is for informational purposes only and is not legal or medical advice. Always consult with your VSO representative or a qualified veterans benefits attorney for guidance on your specific claim.